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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S235cartilage, which were found to stimulate HB-EGF expression. Given the
ﬁnding that HB-EGF signals through the chondrocyte EGFR and
promotes MMP-13 production and that it is present in human OA
cartilage, further evaluation of its role in OA is warranted.
Fig 1. Subnetwork produced by JAMs analysis of gene microarray data at the 4 week
time point after DMM surgery.
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ARTICULAR CARTILAGE EXPRESSES THE IL-15 RECEPTOR ALPHA-
CHAIN AND RESPONDS TO IL-15 WITH INCREASED MATRIX
METALLOPROTEINASE-1 AND -3 RELEASE
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Purpose: IL-15, known for its effects on survival and activation of
lymphocytes, plays a role in promoting synovitis in Rheumatoid
Arthritis. IL-15 serum levels have also been associated with develop-
ment and progression of radiographic OA changes, suggesting a possible
role in cartilage erosion. We previously reported that synovial ﬂuid (SF)
IL-15 levels correlate with levels of matrix metalloproteinase (MMP)-1
and MMP-3 in patients with knee OA. These enzymes inﬂuence carti-
lage matrix remodeling and degeneration. In this study, we investigate
IL-15 and IL-15 receptor expression in cartilage, and test whether IL-15
can induce MMP production from cartilage.
Methods: Cartilage samples from organ donors without a history of
arthritis were collected within 24 hours of death. Extent of joint
structural degeneration in each donor was graded using the modiﬁed
Collins score, and ranged from 0 (normal) to 4 (30% full-thickness
erosion+ osteophytes). Tissues were formalin-ﬁxed and parafﬁn-
embedded. Six-micron sections were stained for IL-15 and IL-15Ra
using standard immunoperoxidase technique and polyclonal antibodies
directed against IL-15 (rabbit anti-human IL-15, Abcam) or the IL-15Ra
chain (goat anti-human IL-15 Ra, Santa Cruz Biotechnology). To test
effects of IL-15 on cartilage, 4mm cartilage punch biopsies were
prepared from the tibial surfaces of seven additional organ donors. For
each donor, 2 explants per well were placed in a 24 well plate with
DMEM (+100U/ml Penicillin-Streptomycin). After 24 hours, media was
replaced with 1 ml of fresh media or media + recombinant human IL-15
(100ng/ml, Peprotech, NJ). TNF-a + Oncostatin M (100ng/ml each, R & D
Systems, MN) was used as a positive control. Every two days for up to 10
days, culture supernatants were collected and replaced with fresh
media +/- cytokines. Consecutive two-day supernatants were analyzed
in duplicate for MMP-1, -3 and -9 using a human MMP 3-Plex Immu-
noassay (Meso Scale Discovery).Results: Staining for IL-15 and IL-15Ra was observed in chondrocytes
from all layers (superﬁcial to deep), regardless of Collins grade. For the
explant experiments, results were expressed as the percentage of the
total ng released in 10 days from the untreated control (¼100%) to allow
comparison between donors. The mean release (n¼7 experiments) in
response to IL-15 after 10 days in culturewas not signiﬁcantly increased
compared to control (MMP-1 release: 841%+/- 675 of control, MMP-3:
204% +/- 127, p>0.05), and MMP-9 release (112% +/-66). However, the
effect of IL-15 on MMP-1 and -3 by release by cartilage explants was
highly variable, and when analyzed individually signiﬁcant increases
were observed in ﬁve of the seven experiments (p<0.05 IL-15 compared
to control). MMP-1 release was observed in explants with grade 1- 4
cartilage degeneration, but not normal (grade 0) cartilage. The greatest
magnitude effect was seen in grade 1 (1521% +/- 10 compared to
untreated control) and grade 4 cartilage (1995% +/- 53).
Conclusions: Both IL-15 and IL-15Ra are expressed in cartilage indi-
cating the potential for this tissue to respond to IL-15. In vitro, IL-15
induced MMP-1, and -3, but not -9 release from cartilage explants, but
the release was highly variable and dependent on the presence of
cartilage integrity loss. This is the ﬁrst demonstration that cartilage is
responsive to IL-15, and suggests a novel role for IL-15 in cartilage
catabolism in various forms of arthritis including OA.
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EARLY TRANSIENT INDUCTION OF IL-6 IN A MOUSE JOINT INJURY
MODEL
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Davis, Sacramento, CA, USA
Purpose: Although the etiology of osteoarthritis (OA) is unknown, it is
often associated with joint injuries. For example, w50% of people with
knee injuries, such as an ACL tear, develop post traumatic osteoarthritis
(PTOA) within 10-20 years. Immediately upon injury, the mechanical
damage causes cell death and physical damage to the surrounding
tissues. This is followed by an acute cellular response, which occurs
within a time-scale of minutes to hours. Based on studies of injury in
other tissues, the acute response phase is characterized by the release of
inﬂammatory mediators, including IL-1, IL-6, and TNFa. In chon-
drocytes, exposure to these cytokines can cause the transcriptional
activation of primary response genes (or inﬂammatory genes), and lead
to increased production of matrix degrading enzymes such as MMPs,
collagenases and aggrecanases. This enzymatic degradation of matrix
contributes to OA via a cascade of destructive events. We believe that
awindow for therapeutic intervention exists shortly after injury, during
which attenuating the acute cellular response will decrease the
production of matrix degrading enzymes and thus decrease the likeli-
hood of developing PTOA.
The acute cellular response within hours of knee injury has not been
studied in detail in a mouse model. We have developed a non-invasive
knee injury mouse model, in which the knee joint is injured by a single
mechanical compression. These mice consistently develop osteoar-
thritis in the injured knees within 2-3 months. We examined the
temporal expression of IL-1b, IL-6, and TNFa and their downstream
target MMP13. Our study characterizes the temporal changes in gene
expression shortly after knee trauma and identiﬁes a window of
opportunity for therapeutic intervention.
Methods: The acute cellular response within hours of knee injury has
not been studied in detail in a mouse model. We have developed a non-
invasive knee injury mouse model, in which the knee joint is injured by
a single mechanical compression. These mice consistently develop
osteoarthritis in the injured knees within 2-3months. We examined the
temporal expression of IL-1b, IL-6, and TNFa and their downstream
target MMP13. Our study characterizes the temporal changes in gene
expression shortly after knee trauma and identiﬁes a window of
opportunity for therapeutic intervention.
Results: IL-6 mRNA expression peaked at 8-hours (w8.5-fold over
control) and returned to base line at 3-day post-injury (Fig. 2). IL-6
Receptor expression was detectable in all samples but remained largely
unchanged relative to control. On the other hand, IL-1bmRNA increased
only slightly (w1.6-fold) but signiﬁcantly at 8 and 24 hours post-injury
and also returned to base line after 3 days. Unexpectedly, the expression
of MMP13, which degrades cartilage matrix and is a downstream target
of IL-1b and TNFa, showed no signiﬁcant change. In contrast, TNFa
expression did not change signiﬁcantly throughout the entire 7-days
time course. Taken together, results from our mouse PTOA model
